InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by McManus Matthew. Director active across 2 companies, notably Azenta, Inc.. In total, 5 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €497k. Activity tracked since 19 August 2022. The latest transaction was filed on 1 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
McManus Matthew is a declarant linked to BIO-TECHNE Corp, where his listed role is President - Diag & Spatial Bio, and to Azenta, Inc., where his listed role is EVP & Chief Operating Officer. He has 5 filings in total, and among the sampled recent filings, the period runs from 2022-08-22 to 2026-02-03, with EUR 497075 of buys and EUR 0 of sells, the most frequent transaction nature being Option exercise.